Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vanda Pharmaceuticals buy marge

Start price
€14.03
30.10.17 / 50%
Target price
€18.86
04.11.21
Performance (%)
11.22%
End price
€15.60
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €15.60. The prediction had a final performance of 11.22%. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Vanda Pharmaceuticals 14.350% 14.350% -10.526% -62.774%
iShares Core DAX® 2.831% 1.236% 14.788% 17.647%
iShares Nasdaq 100 2.918% 0.640% 40.290% 50.762%
iShares Nikkei 225® 2.007% -2.135% 19.861% 4.937%
iShares S&P 500 2.257% 0.451% 30.090% 43.940%

Comments by marge for this prediction

In the thread Vanda Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 11.22%
Target price 28.864
Change
Ends at 04.11.21

Vanda mit positiven Analystenkommentaren


  • Vanda Pharmaceuticals (NASDAQ:VNDA) price target raised to $26 (77% upside) from $21 by Oppenheimer citing more bullish forecasts for Hetlioz (Outperform).



Prediction Buy
Perf. (%) 11.22%
Target price 18.864
Change
Ends at 04.11.21

Kursziel geändert auf 18,864

In the thread Trading Vanda Pharmaceuticals
Prediction Buy
Perf. (%) 11.22%
Target price 18.864
Change
Ends at 04.11.21

Die von marge gewählte maximale Laufzeit wurde überschritten